Location
Australia, Oceania
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Christopher Smith is a Partner at Brandon Capital Partners, specializing in life sciences investment with a focus on early-stage innovations with strong scientific and commercial potential. The firm typically invests between $100K and $5.0M, focusing on pre-seed through seed stages in sectors including Medical Devices, Pharmaceuticals, BioTech, Therapeutics, and Health & Hospital Services. Chris joined Brandon Capital in 2012 after serving as a Business Development Manager with CSL, Australia's largest pharmaceutical company, where he was responsible for identifying and reviewing opportunities for CSL's global R&D pipeline, and he holds a PhD in Immunology from the Walter and Eliza Hall Institute and an MBA from the University of Cambridge.
Previous investments
Similar Investors
Julie Fedele
Pre Seed
,Seed
,Melissa McBurnie
Pre Seed
,Seed
,Gregory Griffiths
Pre Seed
,Seed
,Grant McCarthy
Seed
,Series A
,Dan Fitzgerald
Seed
,Nick Crocker
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free